Advancing
Peptide
Therapies
»
Press Releases
27-Jul-2010
Unigene to Release Second Quarter 2010 Results and Host Conference Call
23-Jul-2010
Unigene Notes Progress of Tarsa's Phase III ORACAL Trial of its Oral Calcitonin for the Treatment of Postmenopausal Osteoporosis
23-Jul-2010
Unigene Reports Continuation of Phase III Study of Oral Calcitonin in Osteoarthritis Patients
9-Jun-2010
Unigene Appoints New CEO, Ashleigh Palmer
Concept
to
Commercialization
»
Why Unigene
»
Our Products
»
Stock Quote
»
Events
© Copyright 2005-2010 Unigene, Inc. ▪
Legal
